Aging is associated with the progressive impairment of autophagy, a cellular process that plays a crucial role in maintaining cellular homeostasis. Dysfunctional autophagy has been linked to the development of aging-related diseases, including neurodegenerative disorders and metabolic syndrome. Therefore, restoring impaired autophagy to its optimal state may represent a promising therapeutic strategy for treating age-related diseases and improving healthspan.
Fig. 1 Geroprotective mechanisms of autophagy and age-related diseases manifest by autophagy dysfunction. (Leidal AM, et al., 2018)
CD BioSciences provides analysis services to evaluate the role of autophagy in aging-related diseases and support the development of therapeutic strategies targeting autophagy.
How Do We Analyze the Role of Autophagy in Aging-Related Diseases?
Analysis of the role of autophagy in disease pathogenesis
We employ various techniques to assess autophagic flux, measure autophagosome formation, and evaluate the expression levels of key autophagy-related proteins. By analyzing autophagic markers and regulatory pathways, we help clients reveal the contribution of autophagy to the development and progression of aging-related diseases. We assess the activation or inhibition status of key signaling pathways, including mTOR, AMPK, and PI3K/Akt, using phosphorylation assays, gene expression analyses, and pathway-specific inhibitor-based experimental approaches.
Analysis of the role of autophagy in disease therapeutic areas
We evaluate the effects of autophagy modulators across multiple aging-related disease models. By comprehensively analyzing autophagic activity, we assist researchers in quantitative analysis of autophagic activity, pathway modulation, and disease-relevant cellular and functional readouts. Using validated in vitro and in vivo models, we support the evaluation of therapeutic efficacy, safety, and toxicity profiles of autophagy-targeted interventions against various diseases.
Therapeutic Areas in Aging-Related Diseases
At CD BioSciences, we provide analysis services to support research and therapeutic development across multiple aging-related disease areas. We offer customized autophagy analysis services designed to meet specific research needs, supporting the study of autophagy mechanisms and the assessment of therapeutic targets in aging-related diseases. Our experienced scientific team delivers comprehensive analytical capabilities across diverse therapeutic and research areas, including:
CD BioSciences provides analysis services to support academic institutions, pharmaceutical companies, and biotechnology companies in investigating the role of autophagy in aging-related diseases. We work closely with clients to design customized experimental strategies aligned with specific research objectives and deliver high-quality, reliable datasets with comprehensive reporting. Our integrated expertise and technical platforms support mechanistic studies as well as the evaluation and development of autophagy-targeted therapeutic strategies in aging-related diseases. If you are interested in our services, please feel free to contact us or make an online inquiry.
References
- Cheon SY, et al. Autophagy, Cellular Aging and Age-related Human Diseases. Exp Neurobiol, 2019, 28 (6): 643-657.
- Leidal AM, et al. Autophagy and the cell biology of age-related disease. Nat Cell Biol, 2018, 20 (12): 1338-1348.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
